Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Clinical
    • Critical Care
    • Procedures
    • COVID-19
  • Practice Management
    • Quality
    • Public Policy
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Learning Portal
    • The Hospital Leader Blog
    • From SHM
    • SIG Spotlight
    • Chapter Spotlight

An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Clinical
    • Critical Care
    • Procedures
    • COVID-19
  • Practice Management
    • Quality
    • Public Policy
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Learning Portal
    • The Hospital Leader Blog
    • From SHM
    • SIG Spotlight
    • Chapter Spotlight

Peripheral Vascular Disorders

  • News

    ‘Major update’ of BP guidance for kidney disease; treat to 120 mm Hg

    March 16, 2021

    “[Chapter one] of the guidelines is devoted to blood pressure measurement ... if [targeting] 120 [mm Hg systolic], the emphasis is on 120 measured properly.”

  • 1
    News

    PCSK9 inhibitors unexpectedly link with lower VTE, aortic stenosis

    April 21, 2020

    Post hoc analyses of data from as many as 46,000 patients showed surprising links between PCSK9 inhibition and reduced rates of VTE and aortic stenosis.

  • News

    Larger absolute rivaroxaban benefit in diabetes: COMPASS

    March 29, 2020

    The new vascular low dose of rivaroxaban has had a slow start, but these results may stimulate use in patients with diabetes and stable disease.

  • 1
    News

    COPD linked to higher in-hospital death rates in patients with PAD

    January 22, 2019

    COPD was an independent predictor of in-hospital death and of pulmonary embolism in PAD patients.

  • 1
    Video

    VIDEO: Rivaroxaban plus aspirin cut cardiovascular events in stable patients 

    August 28, 2017

    BARCELONA – The COMPASS trial produced “unambiguous results that should change guidelines and the management of stable coronary artery disease,” commented Eugene Braunwald, MD.

  • News

    PVC phlebitis rates varied widely, depending on assessment tool

    August 21, 2017

    Rates also varied within individual instruments because they included several possible case definitions.

  • 1
    News

    FDA approves betrixaban for VTE prophylaxis

    June 23, 2017

    An orally administered agent has been approved for VTE prophylaxis in at risk hospitalized patients.

  • News

    Preoperative VTEs occurred in 10% of cancer patients

    March 27, 2017

    SEATTLE – Those with preoperative VTEs were significantly more likely to experience postoperative complications.

  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2000-2023 by the Society of Hospital Medicine and related companies. All rights reserved. ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences